About this trial
The purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors. Participants are asked to wear an ultraviolet (UV) device and an activity monitor (Actigraph) to measure their daily UV exposure and track their physical activity for three separate assessment weeks and complete daily surveys. After the first assessment week, eligible participants are assigned up to 5 different sun protection interventions that are administered through a smartphone application for 8 weeks. Following 8-week use of the sun protection interventions, participants complete another assessment week. At the end of the assessment week, participants provide feedback on the design and usability of the UV device, smartphone application and each of the sun protection interventions that they experienced. One year later, participants are contacted again to complete a final assessment week.
Eligibility criteria
Qualifiers
Is able to speak, read and write in English
Had previous melanoma diagnosis with no melanoma treatment in the last three months
Has no current Melanomas or untreated skin cancer
Reports spending at least 15 minutes outside per day during Spring/ Summer on both weekdays and weekends
Disqualifiers
Has a medical condition preventing moderate-to-vigorous physical activity (MVPA) or a doctor recommendation to avoid MVPA
Is currently enrolled in another study on MVPA
Trial design
Treatments tested in this trial
- UV Real-Time Alerts
- Track Your Sun Protection
- Current Conditions
- Health Coaching
- Action Planning
- Core Components
Treatment groups
32
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Northwestern University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
Huntsman Cancer Institute/ University of Utah
Collaborator
National Cancer Institute (NCI)
Collaborator